SolarEdge is executing a credible operational recovery following a period of significant losses, with concrete steps including U.S. manufacturing consolidation and new SiC-based product launches in Europe. Q4 2025 results beating expectations and strong stock momentum provide near-term confidence. However, the full-year profitability thesis for 2026 is still unproven, the CFO transition adds near-term governance uncertainty, and the stock's extreme appreciation means most of the recovery may already be priced in. Investors should weigh the genuine strategic progress against execution risk, tariff uncertainty, and a valuation that appears to reflect optimistic assumptions rather than demonstrated results.